Other
2028
Amgen 2028 decreased by 20.0% to $2.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.3%, from $3.70B to $2.80B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
A declining trend in these annual projections indicates that the bank's historical acquisition costs are being successfully absorbed.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2028. It reflects the...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_398565Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.40B | $2.40B | $2.50B | $2.50B | $2.40B | $2.50B | $2.50B | $2.50B | $3.90B | $3.90B | $3.90B | $3.70B | $3.70B | $3.50B | $2.80B |
| QoQ Change | — | +0.0% | +4.2% | +0.0% | -4.0% | +4.2% | +0.0% | +0.0% | +56.0% | +0.0% | +0.0% | -5.1% | +0.0% | -5.4% | -20.0% |
| YoY Change | — | — | — | +4.2% | +0.0% | +0.0% | +0.0% | +4.2% | +56.0% | +56.0% | +56.0% | -5.1% | -5.1% | -10.3% | -24.3% |
Range$2.40B – $3.90B
CAGR+4.5%
Avg YoY Growth+11.0%
Median YoY Growth+0.0%
Current Streak2 quarters decline
2028 at Other Companies
Frequently Asked Questions
- What is Amgen's 2028?
- Amgen (AMGN) reported 2028 of $2.80B in Q1 2026.
- How has Amgen's 2028 changed year-over-year?
- Amgen's 2028 decreased by 24.3% year-over-year, from $3.70B to $2.80B.
- What does 2028 mean?
- The expected non-cash expense for acquired intangible assets in the year 2028.